NCT05094843 The Cardiac Stress and Electrocardiographic Changes Caused by Lung Cancer Surgery
| NCT ID | NCT05094843 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tampere University Hospital |
| Condition | Lung Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2022-03-01 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2022-03-01 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Lung cancer surgery causes significant changes in the small circulation as well as changes in the intrathoracic anatomy. The effects of lung cancer surgery on electrocardiography and the cardiac stress associated with the procedures have not been previously extensively studied. The aim of the present study is to ascertain whether modern mini-invasive lung cancer surgery causes changes in the electrocardiogram, and whether these changes are transitory during short-term follow-up. Furthermore, the study aims to describe whether lung cancer surgery causes significant cardiac stress detectable by intraoperative electrocardiography.
Eligibility Criteria
Inclusion Criteria: * Adult patients scheduled for elective lung cancer surgery * Willing to participate in the study * Curatively aimed surgery * Preoperative decision for mini-invasive surgery Exclusion Criteria: * Participation in any other clinical trial * Previous chronic or paroxysmal atrial fibrillation or atrial flutter * Cardiac pacemaker * History of cardiac conduction disturbances including bundle branch blocks * History of cardiac ablation procedures * History of previous surgery in the thoracic area including open heart surgery * Preoperatively anticipated need for concomitant thoracic wall resection * Preoperatively anticipated need for open surgery
Contact & Investigator
Jahangir Khan
PRINCIPAL INVESTIGATOR
MD, PhD
Frequently Asked Questions
Who can join the NCT05094843 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05094843 currently recruiting?
Yes, NCT05094843 is actively recruiting participants. Contact the research team at jahangir.khan@sydansairaala.fi for enrollment information.
Where is the NCT05094843 trial being conducted?
This trial is being conducted at Tampere, Finland.
Who is sponsoring the NCT05094843 clinical trial?
NCT05094843 is sponsored by Tampere University Hospital. The principal investigator is Jahangir Khan at MD, PhD. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.